ATE544474T1 - Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird - Google Patents

Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird

Info

Publication number
ATE544474T1
ATE544474T1 AT08864838T AT08864838T ATE544474T1 AT E544474 T1 ATE544474 T1 AT E544474T1 AT 08864838 T AT08864838 T AT 08864838T AT 08864838 T AT08864838 T AT 08864838T AT E544474 T1 ATE544474 T1 AT E544474T1
Authority
AT
Austria
Prior art keywords
imaging
medium
magnetic resonance
imaging medium
ketoisocaproate
Prior art date
Application number
AT08864838T
Other languages
English (en)
Inventor
Anna Gisselsson
Georg Hansson
Sven Mansson
T Zandt Rene In
Magnus Karlsson
Pernille Jensen
Mathilde Lerche
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Application granted granted Critical
Publication of ATE544474T1 publication Critical patent/ATE544474T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08864838T 2007-12-21 2008-12-19 Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird ATE544474T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20076640 2007-12-21
PCT/EP2008/067986 WO2009080739A1 (en) 2007-12-21 2008-12-19 Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used

Publications (1)

Publication Number Publication Date
ATE544474T1 true ATE544474T1 (de) 2012-02-15

Family

ID=40470026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08864838T ATE544474T1 (de) 2007-12-21 2008-12-19 Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird

Country Status (7)

Country Link
US (1) US20110038804A1 (de)
EP (1) EP2222346B1 (de)
JP (1) JP5351172B2 (de)
CN (1) CN101951963B (de)
AT (1) ATE544474T1 (de)
ES (1) ES2379143T3 (de)
WO (1) WO2009080739A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5570081B2 (ja) 2012-04-27 2014-08-13 株式会社エフ・シー・シー プレス部品の成形方法、プレス部品の製造方法およびプレス部品の成形用金型
US10265421B2 (en) * 2013-01-31 2019-04-23 Bracco Imaging S.P.A. Hyperpolarized esters as metabolic markers in MR
EP3101012A1 (de) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
KR102934987B1 (ko) 2018-11-23 2026-03-09 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
EP4090648A4 (de) * 2020-01-17 2024-06-12 The Government of The United States of America as represented by The Secretary, Department of Health and Human Services Isotope von alpha-ketoglutarat und verwandten verbindungen und deren verwendung in der hyperpolarisierten bildgebung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ552898A (en) * 2004-07-30 2011-02-25 Ge Healthcare As Method of producing a composition, composition and its use
WO2006011810A2 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
JP5475995B2 (ja) * 2005-12-01 2014-04-16 ジーイー・ヘルスケア・アクスイェ・セルスカプ 動的核分極（ｄｎｐ）法
PL1962912T3 (pl) * 2005-12-16 2013-03-29 Ge Healthcare As Sposób wytwarzania hiperpolaryzowanych karboksylanów amin organicznych
WO2008086534A1 (en) * 2007-01-11 2008-07-17 Huntington Medical Research Institutes Imaging agents and methods of use thereof

Also Published As

Publication number Publication date
EP2222346B1 (de) 2012-02-08
ES2379143T3 (es) 2012-04-23
JP5351172B2 (ja) 2013-11-27
CN101951963A (zh) 2011-01-19
JP2011506015A (ja) 2011-03-03
EP2222346A1 (de) 2010-09-01
US20110038804A1 (en) 2011-02-17
WO2009080739A1 (en) 2009-07-02
CN101951963B (zh) 2013-07-17

Similar Documents

Publication Publication Date Title
EP2370593A4 (de) Verfahren zur behandlung von infektionen und tumoren
ATE530558T1 (de) Verfahren und verbindungen zur herstellung von natriumglucose-co-transporter-2-hemmern
DE112006000054A5 (de) Verfahren zur Diagnose eines Abgasnachbehandlungssystems
DE112009000756A5 (de) Verfahren zur Herstellung eines elektronischen Bauelements und elektronisches BAuelement
GEAP202014664A (en) New gadolinium chelate compounds for use in magnetic resonance imaging
CR20140180A (es) Inhibidores macrocíclicos de serina proteasas de hepatitis c
ATE544474T1 (de) Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird
NL2002411A1 (nl) System and method for tissue specific MR imaging of metabolites using spectral-spatially formed stimulated echo.
EP2486385A4 (de) Sonde und verfahren zur ermittelung rheologischer merkmalswerte
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
AT505105A3 (de) Verfahren zur beurteilung der fahrbarkeit von fahrzeugen
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
EP2352067A4 (de) Elektrifizierungselement, verfahren zur herstellung des elektrifizierungselements, prozesskartusche und elektrofotografische vorrichtung
EP2257516A4 (de) Verfahren zur herstellung von cyclododecatrien und verfahren zur herstellung von laurolacton
DE502006005290D1 (de) Niedrigviskose uretdiongruppenhaltige polyadditionsverbindungen, verfahren zur herstellung und verwendung
ATE529738T1 (de) Verfahren zur zerstörungsfreien prüfung von rohren
EP2416538A4 (de) Verfahren zur bereitstellung von knoteninformationen, verfahren für den erhalt von knoteninformationen und ausrüstung dafür
PL2052273T3 (pl) Obrazowanie lub spektroskopia metodą rezonansu magnetycznego 13C śmierci komórkowej
BRPI0908032A2 (pt) Método de aquisição de dados de aceleração de declínio de eco para identificação de gás utilizando baixo gradiente de campo
ATE534408T1 (de) Bildgebungsmedium mit hyperpolarisiertem uüc- acetat und seine verwendung
EP2538172A4 (de) Verfahren zur einstellung eines optischen weggebers und verfahren zur herstellung des optischen weggebers
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE102009058730B8 (de) Verfahren zur Herstellung eines Motorblocks
DE502007007017D1 (de) Verfahren zur herstellung eines einstückigen, metallischen mehrfachrades und mehrfachrad